Nephro-Urology Monthly
Treatment of Advanced Transitional Cell Carcinoma of the Bladder by Irinotecan in an Experimental Animal Model
Abstract
Copyright
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
The Phase 2 Study of "(TOX) Preoperative Chemotherapy" Response Rate and Side Effects in [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and Capcitabine
Yahyazadeh-Jabbari S, Malekpour N, Salmanian B, Foodazi H, Salehi M, et al. The Phase 2 Study of "(TOX) Preoperative Chemotherapy" Response Rate and Side Effects in [Locally Advanced Operable Gastric Adenocarcinoma] Patients With Docetaxel, Oxaliplatin and Capcitabine. Int J Cancer Manag. 2013;6(3):e80420. doi:
Improving Compliance With a Single Post-Operative Dose of Intravesical Chemotherapy After Transurethral Resection of Bladder Tumour
Stroman L, Tschobotko B, Abboudi H, Ellis D, Mensah E, et al. Improving Compliance With a Single Post-Operative Dose of Intravesical Chemotherapy After Transurethral Resection of Bladder Tumour. Nephro-Urol Mon. 2016;8(1):e29967. doi: https://doi.org/10.5812/numonthly.29967
A Preliminary Study of NER and MMR Pathways Involved in Chemotherapy Response in Bladder Transitional Cell Carcinoma: Impact on progression-free survival
Montazeri V, Ghahremani MH, Montazeri H, Hasanzad M, Safavi DM, et al. A Preliminary Study of NER and MMR Pathways Involved in Chemotherapy Response in Bladder Transitional Cell Carcinoma: Impact on progression-free survival. Iran J Pharm Res. 2020;19(1):e124447. doi: https://doi.org/10.22037/ijpr.2020.112646.13878
Comparison of Re-TUR Results in Primary Patients with Non-muscle-Invasive Bladder Cancer (NMIBC) of Low, Intermediate, and High-risk for Recurrence Based on the EORTC Scoring System
Khaleghi Mehr F, Shadpour P, Shahrokh H, Narimani N, Abolhasani M, et al. Comparison of Re-TUR Results in Primary Patients with Non-muscle-Invasive Bladder Cancer (NMIBC) of Low, Intermediate, and High-risk for Recurrence Based on the EORTC Scoring System. Nephro-Urol Mon. 2021;13(2):e99800. doi: https://doi.org/10.5812/numonthly.99800
Comparative Study Between Two Treatment Regimens of Cisplatin-5-Fluorouracil and Gemcitabine-Cisplatin in Gallbladder Cancer Patients
Ali D, Alam N, Yasmin F, Ali S, Anwer T, et al. Comparative Study Between Two Treatment Regimens of Cisplatin-5-Fluorouracil and Gemcitabine-Cisplatin in Gallbladder Cancer Patients. Iran J Pharm Res. 2017;16(2):e125015. doi: https://doi.org/10.22037/ijpr.2017.2038
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 0
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):